ASAM Stimulant Use Disorder Course - 2025

5 (1 vote)

  • Register
    • Non-Member - $199
    • Regular Member - $149
    • Retired - $149
    • Early Career Physician - $149
    • Resident - $99
    • Student - $99
    • Associate - $99
    • ASAM Staff - Free!
    • International Member - $149
    • Emeritus Member - $149
    • Provisional Member - $149
    • Fellow Member - $149
    • Honorary Member - $149
    • CRT Member - $149

ASAM Stimulant Use Disorder

Recorded: Thursday, April 24, 2025
On-Demand Course

Overview

Effectively managing stimulant use disorder requires a comprehensive, patient-centered approach. This course equips healthcare professionals with the understanding and information to inform use of evidence-based tools to diagnose and treat stimulant use disorder, including harm reduction strategies, behavioral interventions, pharmacological treatments, and the management of acute intoxication. Special considerations for long-term health impacts and co-occurring medical or psychiatric conditions are also addressed, ensuring practitioners are prepared to deliver or incorporate holistic care across various clinical settings and levels of care.

The target audience for this advanced level activity includes: physicians, psychologists, addiction specialists and other clinicians part of the care team.

This activity addresses the following ACGME Competencies: Patient Care, Medical Based Knowledge, Practice Based Learning.

Learning Objectives

Upon completion, learners will be able to:

  1. Identify the unique neurobiological and psychosocial characteristics of stimulant use disorder that differentiate it from other substance use disorders.
  2. Apply evidence-based harm reduction strategies and behavioral interventions to engage patients in stimulant use disorder treatment.
  3. Develop comprehensive treatment plans for behavioral interventions and pharmacological treatments in various clinical settings for managing stimulant use disorder.
  4. Implement treatments for both acute intoxication and long-term management of patients with stimulant use disorder, including those with co-occurring medical or psychiatric conditions.

Registration Rates


ASAM Learner TypeRate
ASAM Member$149
Non-Member$199
Associate Member$99
Resident Member*$99
Student Member*$99

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Open Registration: 05/26/2024 - 04/26/2028

Close Access Date: 05/26/2028

Instructions

  1. Click on the Contents tab to begin this activity. 
  2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 13 out of 18 questions correctly.
  3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window. 
  4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Carla Marienfeld

MD, DFAPA, FASAM

Carla Marienfeld, MD, is a board-certified addiction psychiatrist and Clinical Professor at the University of California, San Diego who supports recovery in an evidence based, harm-reduction approach through therapy, motivational interviewing, and medication treatment. Her research involves analysis of electronic medical record data for individuals with substance use disorders. She has authored or co-authored over 35 peer reviewed articles, book chapters, practice guidelines, and invited commentaries, and she edited two books: Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review: An essential board exam study guide. She has been highly involved in education of colleagues and trainees about addiction psychiatry and effective interventions including buprenorphine treatment and motivational interviewing, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale. During her residency, she was chief resident of psychiatry and founded (and later led) the Yale Global Mental Health Program. She earned a medical degree with honors from Baylor College of Medicine in Houston.

Disclosures - Does Disclose:

  • Consultant and stock options: CARI Therapeutics

Brian Hurley

MD, MBA, DFASAM

Brian Hurley, MD, MBA, DFASAM is an addiction physician and the Director of Addiction Medicine for the Los Angeles County Department of Health Services. Brian is currently a Director at Large for the American Society of Addiction Medicine (ASAM) and will assume the position of President-Elect this April 2021. He co-chairs the Los Angeles County Department of Health Services’ Substance Use Disorders Workgroup and the SafeMedLA Medications for Addiction Treatment Action Team, and is the Clinical Director of the Addiction Treatment Starts Here programs through the Center for Care Innovations, focused on increasing the delivery of Medications for Addiction Treatment in California’s community health centers. He is the PI of two MAT Access Points projects funded by the Sierra Health Foundation, a co-PI of a TRDRP funded smoking cessation implementation project, and a co-investigator on NIDA, NIAAA, and PCORI funded addiction related implementation science grants managed through RAND. He is a member of the Motivational Interviewing Network of Trainers and regularly conducts motivational interviewing trainings throughout the United States. He is a Volunteer Assistant Clinical Professor of Addiction Medicine in the Department of Family Medicine at the UCLA David Geffen School of Medicine. He additionally serves on the American Board of Psychiatry and Neurology’s Addiction Psychiatry examination writing committee.

 Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA), and was previously a UCLA - Veterans Administration National Quality Scholar at the VA Greater Los Angeles Healthcare System. He completed a fellowship program in addiction psychiatry at New York University School of Medicine. He completed residency training at the Massachusetts General Hospital and McLean Hospital, where he was Chief Resident in Addiction Psychiatry. Brian is a former National President of the American Medical Student Association.

No relevant financial disclosures

Eve Lasswell

PsyD

UD San Diego Health

Eve Lasswell, PsyD, is a licensed clinical psychologist who treats adults with substance use and co-occurring disorders. Dr. Lasswell is part of UC San Diego Health's Addiction Recovery and Treatment Services, which uses a harm-reduction approach to provide care for all stages of recovery from substance use disorders. She treats patients with co-occurring mental health and substance abuse disorders and helps adults recover from addiction by encouraging behaviors that build wellness and emotional resilience.

 In addition, she has experience helping people with post-traumatic stress disorder (PTSD), depression, and anxiety, as well as concerns related to role transitions and interpersonal relationships.

 Dr. Lasswell also has experience providing care to diverse patient populations, including those with ethnic backgrounds different from her own, LGBTQIA (lesbian, gay, bisexual, transgender, queer or questioning, intersex, and asexual) individuals, and current and former members of the US military.

 Her research aims to improve outcomes for people with substance use disorders and improving access to mental health services for the underserved.

 Dr. Lasswell completed a postdoctoral fellowship in addiction treatment at Veterans Affairs Salt Lake City Health Care System. She earned her doctorate in clinical psychology at Indiana State University.

 She is a member of the American Psychological Association's Society of Addiction Psychology.

 


No Relevant Financial Disclosures. 

 

Siddarth Puri

MD

Sid Puri is an adult, child/adolescent, and addiction psychiatrist. He graduated from UC Davis School of Medicine and completed his adult psychiatry residency, served as chief resident for his child/adolescent fellowship, and addiction psychiatry fellowship at the UCLA Semel Institute. He’s currently the associate medical director of prevention at the Los Angeles County Department of Public Health, Bureau of Substance Abuse Prevention and Control (SAPC). He holds a BA and MA from UCLA in Art History and was a Fulbright Scholar to India. 


No relevant financial disclosures

Stephen P. Murray, MPH, NRP

Director, SafeSpot Overdose Hotline / Adjunct Assistant Clinical Professor

rayken Center for Addiction at Boston Medical Center / Boston University School of Public Health Plymouth, Massachusetts

Stephen Murray, MPH, NRP, is an overdose researcher, Harm Reduction Program Manager and the Director of the SafeSpot Overdose Hotline at Boston Medical Center and an Adjunct Assistant Clinical Professor of Community Health Sciences at Boston University School of Public Health. In 2021, he retired as a Lieutenant at a large regional ambulance service in Western Massachusetts, and had served as a first responder since 2013, having worked both as a firefighter and paramedic. He regularly shares for a national audience about his lived experience as a person who used drugs and overdose survivor. Stephen provides expert technical assistance around the topics of overdose prevention, emergency medical services, workforce and harm reduction to a variety of organizations, county and state governments across the country, including the White House Office of National Drug Control Policy, Commonwealth of Massachusetts, Substance Abuse and Mental Health Services Agency, the National Academies of Medicine, and the National Governors Association. He has guest lectured at over a dozen universities including at Harvard University, University of Southern California, UMASS Medical School, and Georgetown University. He has research published in the International Journal of Drug Policy, Substance Use & Addiction Journal, American Journal of Public Health and Health Promotion Practice. In September 2023, he was featured in the multiple award-winning Episode 809 ("The Call") on This American Life.

No relevant financial disclosures.

Raagini Jawa, MD, MPH, FASAM

Assistant Professor of Medicine

UPMC

Dr. Raagini Jawa is an Assistant Professor and Clinician Investigator in the Center for Research on Health Care, Department of General Internal Medicine at University of Pittsburgh Medical Center. She is board certified in Internal Medicine and Infectious Disease and Addiction Medicine. Dr. Jawa leads the Harm Reduction Research Collaborative team where her research focuses on the intersection of Infectious Disease and Addiction, including studying how to optimize integration of harm reduction services for individuals with substance use disorders within traditional health settings, developing multidisciplinary provider facing interventions to prevent infectious and non-infections complications of drug use. Clinically, she provides office-based addiction treatment in IM Recovery Engagement Program and attends the Endovascular Infection Service at UPMC.

No financial disclosures. 

Dominick DePhilippis, PhD

Deputy National Mental Health Director for Substance Use Disorder

US Department of Veterans Affairs

Dr. DePhilippis is a licensed clinical psychologist with more than 30 years of experience as a clinician, researcher, and educator, predominantly, in the field of substance use disorders (SUD) treatment. He earned his Ph.D in Clinical Psychology in 1992 from Hahnemann University in Philadelphia, PA. He serves as the Deputy National Mental Health Director for Substance Use SUD in the Office of Mental Health in the US Department of Veterans Affairs (VA). He has particular interests and expertise in expanding access to evidence-based SUD treatment and measurement-based SUD care. He is a nationally recognized subject matter expert in Contingency Management (CM) whose work in implementing CM has been published in peer-reviewed scientific journals and featured in media reports in the New York Times, the Washington Post, Scientific American, and National Public Radio. He is a trainer in Motivational Interviewing and Cognitive Behavioral Therapy for Substance Use Disorders. Dr. DePhilippis also is a Member of the Motivational Interviewing Network of Trainers.

No financial disclosures.

Accreditation & Credits

Joint Accreditation Statement
image

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available
  • Physicians: 6 Credits
  • Nurses & NPs: 6 Nursing Contact Hours
  • Pharmacology Hours: 2 Hours
  • PAs: 6 Credits
  • Interprofessional Continuing Education: 6 Credits
  • Certified Counselors: 6 NBCC Contact Hours
    image
    American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)

This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

  • ABIM MOC Points: 6 Medical Knowledge | 6 Patient Safety
  • ABP MOC: 6 Lifelong Learning & Self-Assessment
  • ABS Continuing Certification: 6 Accredited CME
  • ABA MOCA 2.0®*: 6 Lifelong Learning | 6 Patient Safety
    MOCA 2.0® is a trademark of the American board of Anesthesiology®.
    This activity contributes to the CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.

Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.

  • American Board of Addiction Medicine (ABAM)
  • American Board of Preventative Medicine (ABPM)
  • American Board of Psychiatry and Neurology (ABPN)
  • Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions

All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-0227.

Disclosure Information

In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

The complete list of disclosures and designation statements are linked below.

Key:

Complete
Failed
Available
Locked
View On-Demand Recordings
View Course Overview & Welcome
Open to view video.
Open to view video. This video is approximately 15 minutes and was recorded on 4/24/2025.
View Lived Experience: Stimulant Use Disorder
Open to view video.  |  14 minutes
Open to view video.  |  14 minutes This video is approximately 14 minutes and was recorded on 4/24/2025.
View Session 1: Setting the Stage
Open to view video.  |  28 minutes
Open to view video.  |  28 minutes This video is approximately 30 minutes and was recorded on 4/24/2025.
View Session 2: Harm Reduction for Stimulant Use Disorders
Open to view video.  |  48 minutes
Open to view video.  |  48 minutes This video is approximately 48 minutes and was recorded on 4/24/2025.
View Session 3: Behavioral Interventions for Stimulant Use Disorders
Open to view video.  |  42 minutes
Open to view video.  |  42 minutes This video is approximately 42 minutes and was recorded on 4/24/2025.
View Session 4: How to Implement Contingency Management
Open to view video.  |  50 minutes
Open to view video.  |  50 minutes This video is approximately 50 minutes and was recorded on 4/24/2025.
View Session 5: Medications for Stimulant Use Disorder
Open to view video.  |  60 minutes
Open to view video.  |  60 minutes This video is approximately 60 minutes and was recorded on 4/24/2025.
View Session 6: Medical Management of Acute Stimulant Intoxication
Open to view video.  |  45 minutes
Open to view video.  |  45 minutes This video is approximately 45 minutes and was recorded on 4/24/2025.
View Session 7: Health for People with Long-Term Stimulant Use
Open to view video.  |  40 minutes
Open to view video.  |  40 minutes This video is approximately 40 minutes and was recorded on 4/24/2025.
View Lived Experience: Reflections
Open to view video.  |  6 minutes
Open to view video.  |  6 minutes This video is approximately 6 minutes and was recorded on 4/24/2025.
View Course Wrap-Up
Open to view video.  |   Closed captions available
Open to view video.  |   Closed captions available This video is approximately 5 minutes and was recorded on 4/4/2024.
Complete Evaluations & Claim Credit
Complete Post Test
13 Questions  |  10 attempts  |  10/13 points to pass
13 Questions  |  10 attempts  |  10/13 points to pass This post-test has 13 questions and requires 10 out of 13 questions to pass the test.
Complete Evaluation
14 Questions
14 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Complete Presenter Evaluation
9 Questions
9 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Claim Credit & Certificate
Up to 6.00 medical credits available  |  Certificate available
Up to 6.00 medical credits available  |  Certificate available Attendees should claim only the credit commensurate with the extent of their participation in the activity.